CN1057218C - Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method - Google Patents

Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method Download PDF

Info

Publication number
CN1057218C
CN1057218C CN96106739A CN96106739A CN1057218C CN 1057218 C CN1057218 C CN 1057218C CN 96106739 A CN96106739 A CN 96106739A CN 96106739 A CN96106739 A CN 96106739A CN 1057218 C CN1057218 C CN 1057218C
Authority
CN
China
Prior art keywords
chinese medicine
medicine preparation
preparation
ulcer
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN96106739A
Other languages
Chinese (zh)
Other versions
CN1169863A (en
Inventor
谢景龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG HANFANG PHARMACEUTICAL CO Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96106739A priority Critical patent/CN1057218C/en
Publication of CN1169863A publication Critical patent/CN1169863A/en
Application granted granted Critical
Publication of CN1057218C publication Critical patent/CN1057218C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine preparation for treating sore, ulcer and infection caused by external wound. The Chinese medicine preparation contains phellodendron bark, dandelion, honeysuckle flower, forsythia fruit and scolopendra, and has the efficiency for clearing away heat and toxic material, eliminating the swelling, stopping toxin and removing blood stasis for promoting tissue regeneration. The Chinese medicine preparation can be used for treating diseases, such as sore, ulcer, infection caused by external wound, osteomyelitis, vaginitis, etc. The Chinese medicine preparation is easily absorbed, and has no toxic or side effect. The present invention has the advantages that the preparing process adopts a water decoction and ethanol precipitation method which is simple and practical, the medicinal herb resources are rich and cheap, the cost is low, and the efficiency is high.

Description

A kind of Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination and preparation method thereof
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination and preparation method thereof.
For a long time, be vast medical research worker's emphasis problem for treatment skin infection and trauma infection contamination always.Shortcomings such as the existing medicine ubiquity that is used for the treatment of this class disease and taken effect slowly, and curative effect is low, and healing time is long.
" Yizong Jinjian) " day: " carbuncle and cellulitis being originally caused by fire toxin, meridians intercept QI and blood and coagulate ", " five gas are crossed the utmost point, all can heat-transformation light a fire ".The disease that is of skin infection more than has been described, how accumulate due to the skin by fire-toxin, the QI and blood harmony stagnates, meridians intercept, the corruption of intenseness of heat meat forms, and the corruption of intenseness of heat meat, meat rottenly become pus, cut behind the ulceration or trauma infection contamination, its cause of disease is nothing more than " heat " and " fire ", belong to positive disease, heat symptom-complex, in the pathology evolution process, be unable to do without " stasis of blood " word.
The Chinese medicine preparation that the purpose of this invention is to provide a kind of heat-clearing and toxic substances removing, promoting tissue regeneration by removing blood stasis.
Another object of the present invention provides a kind of preparation method of above-mentioned Chinese medicine preparation.
The Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination of the present invention contains Cortex Phellodendri, Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae and Scolopendra, wherein the parts by weight proportioning of various compositions is as follows: Cortex Phellodendri 30-60 part, Herba Taraxaci 30-60 part, Flos Lonicerae 40-80 part, Fructus Forsythiae 60-120 part, Scolopendra 1.6-4.8 part.
The Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination of the present invention adopts is called 12 Fructus Forsythiaes through persons particularly liable to develop skin infection's panacea by ancient Chinese medicine doctor, have heat-clearing and toxic substances removing, blood stasis dispersing and deswelling, the effect of the nuclear evacuation of pus liquid that reduces phlegm, with removing waste heat in the infections fire from go out, wet in the dry infections and Cortex Phellodendri that pus subtracts certainly is combined into monarch drug; The malicious skin ulcer key medicine Flos Lonicerae of controlling that looses to subside a swelling is a ministerial drug; The Herba Taraxaci of examining, specially treating malicious acute mastitis with heat-transformation poison, detumescence is an adjuvant drug, is used for strengthening the merit of its removing toxic substances and promoting subsidence of swelling, dissipating blood stasis evacuation of pus; Scolopendra with merit poison eliminating stagnation, removing obstruction inchannels to removing blood stasis is a messenger drug, monarch, minister, help, make all medicines to share, make Chinese medicine preparation of the present invention have the special effect of removing toxic substances and promoting subsidence of swelling, stasis-dispelling and pain-killing, putrefaction-removing granulation-promoting, the evacuation of pus of reducing phlegm, can make that patient poison removing the necrotic tissue takes off, passages through which vital energy circulates mediation, abundant, the new meat of QI and blood be spontaneous.
Below by observing case 425 examples, wherein adopt the treatment of Chinese medicine preparation of the present invention to organize 305 examples, adopt matched group 120 examples of existing commercially available medicament, the clinical effectiveness of Chinese medicine preparation of the present invention is described.
According to Principle of Statistics, under the prerequisite of treatment group and matched group patient's sex there was no significant difference, patient age there was no significant difference, under two groups of patient's Western medicine diagnose there was no significant differences, course of disease there was no significant difference, tcm symptom there was no significant difference, sign there was no significant difference, skin ulcer area and ulcer degree of depth there was no significant difference, state of an illness there was no significant difference and physico-chemical examination there was no significant difference, illustrate that two groups of patients have comparability.
During contrast therapy, the Therapeutic Method of treatment group is: the sliver that directly will be soaked with Chinese medicine preparation of the present invention spreads in the infected wound outward, or in the abscess of ulceration, if ulcer is darker, the aseptic sebific duct of available diameter 0.5~1.0cm, insert the ulcer bottom, extract Chinese medicine preparation flushing of the present invention with syringe, more than all once a day.The Therapeutic Method of another matched group is: the rehabilitation of producing with Kunming rehabilitation pharmaceutical factory newly directly spreads on the skin ulcer face or makes sliver and fill in the ulcer or the pipe flushing down of darker ulcer inadequate drainage, once a day.
In the therapeutic process, wound surface 2cm 2In, ulcer degree of depth 1cm was a course of treatment with interior person with 10 days; Wound surface 2cm 2More than, the ulcer degree of depth surpasses 1cm person, is a course of treatment with 20 days.
Judge that the observed project of therapeutic outcome has:
1. clinical symptoms and disease are waited: pain degree and healing state, dysfunction have not and recovery situation, traditional Chinese medical science disease such as thirsty, big dry stool, yellowish urine, heating, tongue, arteries and veins etc.
2. sign: skin ulcer face size and healing state, the ulcer degree of depth and recovery situation, redness has that it's too late degree, granulation tissue situation, secretions character and amount, pus color, pus amount what and pus flavor.
3. physico-chemical examination: total white blood cells and classification, urine is routine, antibacterial culturing, liver, renal function, Chest X-rays etc. just.
Through series of observation and detection, contrast therapy result is as follows:
Two groups of dark ulcer healing natural law are relatively as table 1
The dark ulcer healing natural law of table 1 liang group relatively group mean depth cm ((X ± SD) treatment group 2.24 ± 2.46 10.17 ± 4.02 matched group 1.72 ± 0.58 14.19 ± 3.38 liang group symptom curative effect is relatively as table 2 for the healing natural law of X ± SD)
Table 2 liang group symptom curative effect relatively
Treatment group matched group symptom p value
Treatment back cure rate before the cure rate treatment of treatment back before the treatment
(example), (example), (%), (example), (example), just (%) 77 7 90.91 25 7 72 p<0.01 liang of group sign curative effect is done relatively such as table 3 in red and swollen 284 19 93.30 111 49 55.86 p in pain 290 7 97.58 115 29 74.78 p<0.01<0.01 dysfunction, 126 5 96.03 49 12 75.51 p<0.01 heating thirsty 81 4 95.06 28 5 82.14 p in 119 4 96.64 43 11 74.42 p<0.01<yellow 102 4 96.08 26 5 80.77 p of 0.01 urine<0.01
Table 3 liang group sign curative effect relatively
Treatment group matched group symptom p value
Treatment back cure rate before the cure rate treatment of treatment back before the treatment
(example), (example), (%), (example), (example), (%) compare such as table 4 before and after red and swollen 284 19 93.30 111 47 57.66 p<0.01 granulation oedema, 155 6 96.13 53 19 64.15 p<not bright 215 14 93.49 80 34 57.5 p of 0.01 granulation<0.01 purulent secretion, 236 3 98.73 88 24 72.72 p<0.01 slurry sexual secretion, 73 5 93.15 31 7 77.42 p<smelly 39 2 94.87 13 5 61.54 p of 0.01 purulence<0.01 liang of group tongue arteries and veins curative effect
Compare before and after the table 4 liang group arteries and veins treatment
144 51 147 119 groups of normalization rates of constant, the 95.36 92.27 97.35 95.20 convection potential precedents several 55 33 57 51 of becoming a full member after the thin yellow arteries and veins number treatment precedent several 151 55 151 125 of the yellow thick coating of red tongue body tongue is treated are become a full member 76.36 66.66 84.21 76.47 liang of groups of 42 22 48 39 groups of normalization rates of constant Bacteria Culture situation relatively such as table 5 after shining and treating
Table 5 liang group antibacterial culturing situation relatively
The total routine number of other group of staphylococcus aureus e coli bacillus pyocyaneus
Treat before treating to treat before the back is treated to treat before the back is treated and treat the back treatment before the back is treated and organize 114 43 0 53 1 14 120 matched groups, 47 15 6 20 12 8410 liang of groups state of an illness (severe) and change relatively as table 6
The relation of the table 6 liang group state of an illness and curative effect
The severe group
Recovery from illness produce effects enabledisable worsens the obvious effective rate treatment and organizes 68 10 550 88.63% matched groups 614 15 0 26.92%
More than each the table the data of respectively organizing learn processing by statistics, p illustrates that all less than 0.01 correction data has significant difference.Wherein X is a meansigma methods, and SD is a deviation.
Two groups of total effectses are relatively as table 7
Table 7 liang group total effects relatively group recovery from illness produce effects enabledisable worsens total effective rate treatment group example 258 25 15 70 97.70%
% 84.59 8.19 4.91 2.29 matched group examples 54 20 20 26 0 78.33%
% 45 16.61 16.61 21.61
Two groups of above total effects comparative results, learn by statistics and handle p<0.01, illustrate that two groups of total effectses have significant difference, promptly adopt the total effective rate of treatment group of Chinese medicine preparation of the present invention and obvious effective rate, cure rate all apparently higher than the matched group that adopts " rehabilitation is new ".
By above 425 routine YANG syndrome skin infection and trauma infection contamination patient clinical observation result are shown, Chinese medicine preparation treatment skin infection of the present invention and trauma infection contamination determined curative effect, total effective rate 97.7%, obvious effective rate 92.78%, cure rate 84.59%, easy to use, the congestion and swelling pain around the skin infection,, edema not bright to granulation and secretions all there are better curative effect.The heating that may occur skin infection in addition, thirsty, simultaneous phenomenons such as yellowish urine is red, constipation with dry stool also all can be along with the good of skin infection then disappear.And in clinical trial, all case is not found any whole body or local untoward reaction, illustrate that Chinese medicine preparation of the present invention has no side effect, safe and reliable, there is not any contraindication, wide accommodation can remedy the clinical deficiency that lacks conventional medicine for external use such as " normal saline " that resemble doctor trained in Western medicine, " ethacridine " of surgery of Chinese medicine.The function heat-clearing and toxic substances removing, reducing swelling and alleviating pain, putrefaction-removing granulation-promoting promotes wound healing, improves non-specific immunity.Can treat skin infection burst back or incision and drainage and diseases such as trauma infection contamination, carbuncle, bone tuberculosis, osteomyelitis, burn and scald, cervical erosion and vaginitis, have easy absorption, rapid-action, advantage that curative effect is high.
Chinese medicine preparation of the present invention is like this preparation: Cortex Phellodendri, Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae and Scolopendra water are decocted the back concentrate decoction liquor, carry out precipitate with ethanol with ethanol, filter, get filtrate, steam behind the ethanol adding distil water cold preservation that stirs.
The described precipitate with ethanol of the preparation method of Chinese medicine preparation of the present invention, purpose are the impurity of removing in the decoction liquor.
The preparation method of Chinese medicine preparation of the present invention can also comprise carries out suction strainer with the solution after the cold preservation, removes precipitation.
The preparation method of Chinese medicine preparation of the present invention can also comprise and will carry out disinfection after the solution packing after the cold preservation.
The preparation method of the Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination of the present invention is scientific and reasonable, simple for process, and the medicine source is enriched inexpensive, and cost is low, and high efficiency is easy to promote.
The present invention will be further described below in conjunction with embodiment.
Embodiment
Take by weighing following raw material respectively:
Cortex Phellodendri 50g, Herba Taraxaci 50g, Flos Lonicerae 60g, Fructus Forsythiae 90g, Scolopendra 3g
With above-mentioned all raw material mixing decoctings, add ethanol after decoction liquor concentrated and carry out precipitate with ethanol, remove contamination precipitation, obtain filtrate after the filtration, carry out ethanol and reclaim back adding distil water mix homogeneously cold preservation, with suction filtration precipitation is removed the back packing, carrying out disinfection is finished product again.
This Chinese medicine preparation has heat-clearing and toxic substances removing, reducing swelling and alleviating pain, and the effect of promoting tissue regeneration by removing blood stasis can be treated skin infection or incision and drainage and trauma infection contamination, carbuncle, bone tuberculosis, osteomyelitis, burn and scald, cervical erosion, vaginitis etc.
This Chinese medicine preparation can use like this: the sliver that directly will be soaked with this Chinese medicine preparation spreads in the infected wound outward, or in the abscess of ulceration, if ulcer is darker, the aseptic sebific duct of available diameter 0.5-1.0cm, insert the ulcer bottom, extract the flushing of this Chinese medicine preparation with syringe, once a day.

Claims (4)

1, a kind of Chinese medicine preparation that is used for the treatment of skin infection and trauma infection contamination, it is characterized in that be by the raw material of following parts by weight through decocting, concentrate, add water behind the precipitate with ethanol and make:
30~60 parts of 30~60 parts of Herba Taraxacis of Cortex Phellodendri
60~120 parts of 40~80 parts of Fructus Forsythiaes of Flos Lonicerae
1.6~4.8 parts of Scolopendras.
2, a kind of preparation method of Chinese medicine preparation as claimed in claim 1, it is characterized in that Cortex Phellodendri, Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae and Scolopendra water are decocted the back concentrates decoction liquor, carry out the precipitate with ethanol after-filtration with ethanol, filtrate is steamed ethanol, the cold preservation of adding distil water mix homogeneously.
3, preparation method as claimed in claim 2 is characterized in that the solution after the cold preservation is carried out suction strainer.
4, preparation method as claimed in claim 2 is characterized in that and will carry out disinfection after the solution packing after the cold preservation.
CN96106739A 1996-07-01 1996-07-01 Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method Expired - Lifetime CN1057218C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96106739A CN1057218C (en) 1996-07-01 1996-07-01 Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96106739A CN1057218C (en) 1996-07-01 1996-07-01 Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method

Publications (2)

Publication Number Publication Date
CN1169863A CN1169863A (en) 1998-01-14
CN1057218C true CN1057218C (en) 2000-10-11

Family

ID=5119351

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96106739A Expired - Lifetime CN1057218C (en) 1996-07-01 1996-07-01 Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method

Country Status (1)

Country Link
CN (1) CN1057218C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
EP1325682A1 (en) * 2001-12-11 2003-07-09 Societe Des Produits Nestle S.A. Food or pet food composition containing plant extracts for maintenance of bone health and prevention or treatment of bone diseases
CN103070928B (en) * 2013-01-05 2014-10-08 山西农业大学 Cataplasm of veterinary traditional Chinese medicine clearing away heat and toxic materials and preparation method of cataplasm
CN107582698A (en) * 2017-10-27 2018-01-16 于忠和 A kind of preparation method for the Chinese medicine for treating scald
CN108245622A (en) * 2018-02-24 2018-07-06 山东汉方制药有限公司 A kind of preparation method and applications of Chinese medicine composition
CN108992481A (en) * 2018-10-12 2018-12-14 张金木 For anti-curing oncoma and the Chinese medicine composition of osteomyelitis and preparation method thereof
CN113975327A (en) * 2021-12-10 2022-01-28 山东汉方制药有限公司 Application of compound phellodendron bark liquid liniment in preparing medicine for treating myeloproliferative tumor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中国中西医结合杂志 1994 14卷第4期 1994.1.1 作者,扬宝民,蔡建荣,陈瑞文等 标题 微波热疗加溃疡灵治理\料溃疡 *
江苏中医 92-13-4 1992.1.1 作者,谢正平 标题 溃疡灵液治料36例 *
河南医学学报 1990年第13卷第4期 1990.1.1 作者 谢正平 标题 自拟通络解毒汤治料小腿慢性溃疡27例 *
河南医学学报 1990年第13卷第4期 1990.1.1 作者 谢正平 标题 自拟通络解毒汤治料小腿慢性溃疡27例;江苏中医 92-13-4 1992.1.1 作者,谢正平 标题 溃疡灵液治料36例;中国中西医结合杂志 1994 14卷第4期 1994.1.1 作者,扬宝民,蔡建荣,陈瑞文等 标题 微波热疗加溃疡灵治理\料溃疡 *

Also Published As

Publication number Publication date
CN1169863A (en) 1998-01-14

Similar Documents

Publication Publication Date Title
CN100350951C (en) External-applied medicine for treating burn, valnus and local tumor inflammation
CN1268365C (en) Ointment for treating burns and scalds and its preparation
CN1739638A (en) Medicine for treating dermatosis and its prepn
CN1079152A (en) Preparation method of quick-acting bone injury medicine
CN1057218C (en) Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method
CN103041177B (en) Chinese medicament for treating diabetic foot
CN204723468U (en) A kind of skin wound treatment system for wound debridement, administration oxygen supply
CN1052420C (en) Chinese medicine for curing burn and traumatic wound and its production method
CN105126235A (en) Skin wound treating system used for debridement and drug administration and oxygen supply
CN1263482C (en) External-use Chinese medicine preparation for treating anal-intestinal disorder and its preparing method
CN111298053A (en) Bezoar dragon bone ointment for treating hemorrhoid
CN101554398B (en) Externally applied medical ointment for treating surgical infection and gout and preparation method thereof
CN1418674A (en) Medicine compositions for treating acne, and its prepn. method
CN112156225A (en) Chitosan or and algal polysaccharide composite biological matrix liquid dressing gel preparation and preparation method thereof
CN1137713C (en) Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method
CN1238031C (en) Oral liquid for treating virus coryza and throat disease and its preparation technology
CN108567868A (en) A kind of routed more external medicine composition and preparation method thereof of skin care
CN106511770A (en) Traditional Chinese medicine preparation treating herpes zoster and preparing method of traditional Chinese medicine preparation
CN101983645A (en) Medicament for treating acute appendicitis
CN1326753A (en) Musk skin growing ointment
CN1269499C (en) Medicine efficacious for burn and preparation method
CN106822524B (en) Compound medicine for treating infertility and preparation method and application thereof
CN1055222C (en) Medical ointment (powder) for removing necrotic tissue and promoting tissue regeneration
CN1137707C (en) Skin rehabilitation medicine for treating burn and scald
CN1270748C (en) Chinese medicinal composition for treating sore and wound infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANG HONGBIN

Free format text: FORMER OWNER: XIE JINGLONG

Effective date: 20020809

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20020809

Address after: 250031 Shandong Province Flyover District of Ji'nan city. Shandong Road No. 38 room 2706 Hall of Times Building

Patentee after: Jiang Hongbin

Address before: 050700 Xinle osteomyelitis Hospital of Hebei Province, 45 Xin Xin Street, Hebei, Xinle

Patentee before: Xie Jinglong

ASS Succession or assignment of patent right

Owner name: JINAN BENCAOTANG MEDICAL SCIENCE DEVELOPMENT CO.,

Free format text: FORMER OWNER: JIANG HONGBIN

Effective date: 20040325

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20040325

Address after: 250031 Shandong Province Flyover District of Ji'nan City Road 25.

Patentee after: Ji'nan bencaotang pharmaceutical science and technology development limited liability company

Address before: 250031 Shandong Province Flyover District of Ji'nan city. Shandong Road No. 38 room 2706 Hall of Times Building

Patentee before: Jiang Hongbin

ASS Succession or assignment of patent right

Owner name: SHANDONG HANFANG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: JINAN BENCAOTANG MEDICAL SCIENCE DEVELOPMENT CO., LTD.

Effective date: 20060818

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20060818

Address after: Strong Jibei Development Zone Street Ji'nan city Shandong province 251400

Patentee after: Shandong Hanfang Pharmaceutical Co., Ltd.

Address before: 250031 Shandong Province Flyover District of Ji'nan City Road 25.

Patentee before: Ji'nan bencaotang pharmaceutical science and technology development limited liability company

CX01 Expiry of patent term

Granted publication date: 20001011

EXPY Termination of patent right or utility model